CABIO(SH:688089)2025-04-14 10:05Financial Performance - For Q1 2025, the company expects revenue of approximately 155.96 million yuan, a year-on-year increase of about 33.28%[3] - The net profit attributable to the parent company for Q1 2025 is projected to be between 43.50 million yuan and 48.00 million yuan, representing a year-on-year growth of 78.92% to 97.43%[3] - The net profit attributable to the parent company after deducting non-recurring gains and losses is estimated to be between 39.70 million yuan and 43.80 million yuan, reflecting a year-on-year increase of 110.59% to 132.34%[3] - In Q1 2024, the company's revenue was 117.02 million yuan, and the net profit attributable to the parent company was 24.31 million yuan[5] - The earnings per share for Q1 2024 was 0.14 yuan per share[5] Revenue Drivers - The increase in revenue is primarily due to higher sales of core products ARA and algal oil DHA, along with improved production efficiency and optimized product and customer structures[7] Financial Reporting and Forecast - The financial data for the current period is unaudited and based on preliminary calculations by the finance department[4] - The company has not identified any significant uncertainties that could affect the accuracy of the earnings forecast[8] - Investors are advised to note that the forecast data is preliminary and the final figures will be disclosed in the official Q1 2025 report[9] - The announcement was made by the company's board on April 15, 2025[10]